Status:
COMPLETED
ATEM (Alvesco Non-interventional Study)
Lead Sponsor:
AstraZeneca
Conditions:
Asthma
Allergy
Eligibility:
All Genders
18+ years
Brief Summary
The aim of the study is to evaluate the efficacy of Alvesco in patients with persistent asthma including or excluding allergic components over 3 months, especially in the spring season. Alvesco will b...
Eligibility Criteria
Inclusion
- Main
- Asthma with or without allergic components
- Main
Exclusion
- Hypersensitive to compounds of Alvesco
- Other criteria as defined in the Summary of Product Characteristics, Chapter 4.3
Key Trial Info
Start Date :
March 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2011
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT01147224
Start Date
March 1 2010
End Date
August 1 2011
Last Update
December 5 2016
Active Locations (79)
Enter a location and click search to find clinical trials sorted by distance.
1
Nycomed Pharma GmbH
Amstetten, Austria, 3300
2
Nycomed Pharma GmbH
Baden, Austria, 2500
3
Nycomed Pharma GmbH
Bludenz, Austria, 6700
4
Nycomed Pharma GmbH
Böhlerwerk, Austria, 3333